2012
DOI: 10.1016/j.clinbiochem.2012.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Serum levels of protein S100B predict intracranial lesions in mild head injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 37 publications
(22 citation statements)
references
References 29 publications
0
22
0
Order By: Relevance
“…The peritraumatic amnesia was determined by the patient ' s ability to recall events they can remember immediately before and a er the injury. Inclusion criteria were the same as those described in a previous study [16] . Ethics approval for the collection of samples was obtained from the local committee.…”
Section: Serum Samples From Patients With Mtbimentioning
confidence: 99%
“…The peritraumatic amnesia was determined by the patient ' s ability to recall events they can remember immediately before and a er the injury. Inclusion criteria were the same as those described in a previous study [16] . Ethics approval for the collection of samples was obtained from the local committee.…”
Section: Serum Samples From Patients With Mtbimentioning
confidence: 99%
“…The globally valuable diagnostic performance of MPV for identification of brain injury in patients with MHT (i.e. AUC of 0.74; P ¼ 0.001) also provides a reliable basis for planning further investigations to establish whether this parameter, alone or in combination with other promising biomarkers such as protein S100B [5], may be useful for diagnostic evaluation of MHT in the ED. Distribution of median and interquartile range (IQR) values of mean platelet volume (MPV) in patients with mild head trauma.…”
Section: Discussionmentioning
confidence: 96%
“…Although a kaleidoscope of serum biomarkers is now available for diagnostics of several human diseases, only a few were proven to have clinical usefulness in patients with neurological disorders so far. In particular, only the protein S-100B has shown clinical value in ruling out MHT patients without ICI, with potential saving of 20-30% computerized tomography scans [5].…”
Section: Introductionmentioning
confidence: 99%
“…Some biological markers of brain injury have recently been proposed, including protein S100B, neuron-specific enolase (NSE), glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), cleaved Tau protein (CTP), brain type fatty acid-binding protein (B-FABP), kallikrein 6 (KLK6), ubiquitin C-terminal hydrolase (UCH-L1) and II-spectrin breakdown product 145 kDa (SBDP145), among others. [6][7][8][9][10] Although encouraging results have been published about the potential usefulness of some of these biomarkers in research studies, especially protein S100B, 11,12 there is still limited clinical evidence to allow recommendation of routine implementation for diagnosis and management of patients with MHI. 13,14 Red blood cell (RBC) distribution width (RDW) is a measure of anysocytosis, which is commonly used in combination with mean corpuscular volume (MCV) for investigating the underlying cause(s) of anemia.…”
Section: Introductionmentioning
confidence: 99%